Загрузка...
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
PURPOSE: Revefenacin, a long-acting muscarinic antagonist for nebulization, has been shown to improve lung function in patients with chronic obstructive pulmonary disease. Here we report pharmacokinetic (PK) and safety results from two multicenter, open-label, single-dose trials evaluating revefenac...
Сохранить в:
| Опубликовано в: : | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790214/ https://ncbi.nlm.nih.gov/pubmed/31632000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S203709 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|